The real-world use of istradefylline for Parkinsons disease: Post-marketing surveillance of safety and effectiveness in Japan

被引：0
|
作者：
Takahashi, Makio [1 ]
Itou, Satoru [2 ]
Horiguchi, Shuji [2 ]
Tsuji, Yukie [2 ]
机构：
[1] Kitano Hosp, Tazuke Kofukai Med Res Inst, Osaka, Japan
[2] Kyowa Kirin Co Ltd, Kyowa, Hokkaido, Japan
来源：
NEUROLOGY | 2022年 / 98卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Real-world safety and effectiveness of nivolumab for advanced renal cell carcinoma in Japan: a post-marketing surveillance
    Hirotsugu Uemura
    Yoshihiko Tomita
    Norio Nonomura
    Kenji Yoshizaki
    Takafumi Nakao
    Nobuo Shinohara
    [J]. International Journal of Clinical Oncology, 2022, 27 : 1061 - 1067
  • [2] Real-world safety and effectiveness of nivolumab for advanced renal cell carcinoma in Japan: a post-marketing surveillance
    Uemura, Hirotsugu
    Tomita, Yoshihiko
    Nonomura, Norio
    Yoshizaki, Kenji
    Nakao, Takafumi
    Shinohara, Nobuo
    [J]. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2022, 27 (06) : 1061 - 1067
  • [3] Real-world safety and effectiveness of anamorelin for cancer cachexia: Interim analysis of post-marketing surveillance in Japan
    Takayama, Koichi
    Kojima, Ai
    Honda, Chikara
    Nakayama, Masahiro
    Kanemata, Satomi
    Endo, Toshimitsu
    Muro, Kei
    [J]. CANCER MEDICINE, 2024, 13 (09):
  • [4] Real-world safety and effectiveness of rotigotine in patients with Parkinson's disease: analysis of a post-marketing surveillance study in Japan
    Ito, Hidefumi
    Takayama, Tomoyo
    Kondo, Hiroyuki
    Fukuta, Yasuhiko
    [J]. INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2022, 132 (03) : 237 - 247
  • [5] Safety and effectiveness of istradefylline in patients with Parkinson's disease: interim analysis of a post-marketing surveillance study in Japan
    Takahashi, Makio
    Fujita, Masaki
    Asai, Naoko
    Saki, Mayumi
    Mori, Akihisa
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2018, 19 (15) : 1635 - 1642
  • [6] Real-world safety and effectiveness of nivolumab for recurrent or metastatic head and neck cancer in Japan: a post-marketing surveillance
    Tahara, Makoto
    Kiyota, Naomi
    Nibu, Ken-ichi
    Akamatsu, Ayumi
    Hoshino, Tomohiro
    Hayashi, Ryuichi
    [J]. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2021, 26 (09) : 1619 - 1627
  • [7] Real-world safety and effectiveness of nivolumab for recurrent or metastatic head and neck cancer in Japan: a post-marketing surveillance
    Makoto Tahara
    Naomi Kiyota
    Ken-ichi Nibu
    Ayumi Akamatsu
    Tomohiro Hoshino
    Ryuichi Hayashi
    [J]. International Journal of Clinical Oncology, 2021, 26 : 1619 - 1627
  • [8] Real-world effectiveness and safety of ibrutinib in relapsed/refractory mantle cell lymphoma in Japan: post-marketing surveillance
    Maruyama, Dai
    Omi, Ai
    Nomura, Fumi
    Touma, Tokiko
    Noguchi, Yukiko
    Takebe, Kyoko
    Izutsu, Koji
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2024, 119 (02) : 146 - 155
  • [9] Real-world effectiveness and safety of ibrutinib in relapsed/refractory mantle cell lymphoma in Japan: post-marketing surveillance
    Dai Maruyama
    Ai Omi
    Fumi Nomura
    Tokiko Touma
    Yukiko Noguchi
    Kyoko Takebe
    Koji Izutsu
    [J]. International Journal of Hematology, 2024, 119 : 146 - 155
  • [10] Real-World Safety and Effectiveness of Golimumab in Rheumatic Diseases: Post-Marketing Surveillance in Korea
    Hyeongyeong Kim
    Youngdoe Kim
    YoungJa Lee
    [J]. Rheumatology and Therapy, 2021, 8 : 1393 - 1404
12345